New research finds that rates of GLP-1 use and misuse are shockingly high among people with a history of eating disorders.

This group may be taking the weight-loss drugs in contraindicated ways, researchers suggest

New research finds that rates of GLP-1 use and misuse are shockingly high among people with a history of eating disorders.

Researchers found that 32% of patients with eating disorders report having used a weight loss injection at least once.

New research has identified a potential, if small, added risk of smell and taste disturbances linked to GLP-1 use.